Express Scripts (ESRX) is up slightly after Jeffries analyst calls it "the most mis-priced stock in our coverage universe." Jeffries notes Express Scripts' pending merger with Medco Health (MHS) remains on track, and that synergies are expected to be worth around $1B. The firm also isn't concerned about fears of lost business with Walgreen (WAG).
ESRX is up 0.33 to $44.00
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment